Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 2Dermatologic 2Sarcoma 1Other solid neoplasm 1NET 1Lymphoid 1Head & Neck 1Gynecologic 1Genitourinary 1Endocrine 1Breast 1

Conditions

Pancreatic Neoplasms 50Colorectal Neoplasms 39Stomach Neoplasms 27Carcinoma, Hepatocellular 26Ovarian Neoplasms 25Melanoma 21Breast Neoplasms 20Carcinoma, Non-Small-Cell Lung 19Neoplasms 15Neoplasm Metastasis 15Colonic Neoplasms 14Esophageal Neoplasms 13Uterine Cervical Neoplasms 11Sarcoma 10Liver Neoplasms 10Carcinoma, Renal Cell 10Lung Neoplasms 9Anus Neoplasms 9Rectal Neoplasms 8Head and Neck Neoplasms 8Squamous Cell Carcinoma of Head and Neck 7Osteosarcoma 7Triple Negative Breast Neoplasms 6Mesothelioma 6Hepatoblastoma 6Gastrointestinal Neoplasms 6Carcinoma 6Adenocarcinoma 6Vaginal Neoplasms 5Small Cell Lung Carcinoma 5

Interventions

pembrolizumab 7Nivolumab 3fludarabine 2durvalumab 2avelumab 2atezolizumab 2Cyclophosphamide 2tremelimumab 1fludarabine phosphate 1epacadostat 1bintrafusp alfa protein, human 1aldesleukin 1Therapeutics 1Temozolomide 1Surgical Procedures, Operative 1Specimen Handling 1Oxaliplatin 1Neoadjuvant Therapy 1Ipilimumab 1Interleukin-2 1Injections 1High-Throughput Nucleotide Sequencing 1Educational Status 1Drug Therapy 1Docetaxel 1Chemotherapy, Adjuvant 1Carboxylesterase 1Capecitabine 1Bevacizumab 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Microsatellite Instability × Cyclophosphamide × Gastrointestinal × Clear all
NCT03935893 2026-06-01

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

University of Pittsburgh

Phase 2 Active not recruiting
20 enrolled
DermatologicEndocrineGastrointestinalNETOther solid neoplasmSarcomaThoracic

Turcot syndrome, Mesothelioma, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Neuroendocrine Tumors, Microsatellite Instability

NCT03841110 2023-05-01

FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors

Fate Therapeutics

Phase 1 Completed
37 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidThoracic

Breast Neoplasms, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Lymphoma, Melanoma, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Microsatellite Instability, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡